Latest Charles River Laboratories News & Updates
See the latest news and media coverage for Charles River. We track all announcements, press releases, and industry mentions in real time, all in one place.
Contract research, development, and manufacturing services for drugs and biologics
criver.com- Headquarters
- Wilmington, United States
- Founded year
- 1947
- Company type
- Public company
- Number of employees
- 10,000+
Last updated
Latest news about Charles River Laboratories (Charles River)
In short: Charles River appointed Birgit Girshick as CEO following Jim Foster's retirement and reaffirmed its 2026 earnings guidance despite a revenue trim.
Company announcements
-
Charles River announces Q1 2026 results
Revenue reaches $995.8 million, up 1.2%. Non-GAAP EPS is $2.06. Reaffirms 2026 guidance. Completes CDMO divestiture. Repurchases $200 million stock.
-
Charles River appoints Birgit Girshick CEO
She brings purpose-driven leadership serving clients, patients, animals, and 20,000 colleagues worldwide. The company anticipates strong momentum ahead.
-
Charles River launches rat in vitro fertility services
The service accelerates rat-model programs in oncology, neurology, and other areas using embryo transfer and cryopreservation. It reduces breeding bottlenecks and supports the 3Rs.
-
Charles River highlights VCGs effectiveness in toxicology
Peer-reviewed analysis shows 100% concordance in NOAEL using virtual control groups, reducing animal use while maintaining scientific integrity. Ongoing research refines models.
Media coverage
-
Charles River reaffirms 2026 EPS $10.80-$11.30, targets ~120-150 bps margin expansion as divestitures close
Q1 2026 earnings call recap: guidance reaffirmed, cost savings, divestitures, and 2H margin ramp outlook—read now.
-
GI Partners Completes Acquisition of the CDMO and Cell Solutions Businesses from Charles River Laboratories and forms Rose BioSolutions
GI Partners, a leading private investment firm, today announced it has completed the acquisition of the Contract Development and Manufacturing Organization (CDMO) and Cell Solutions...
-
Charles River Laboratories Trims FY26 Revenue Growth Outlook; Slips To Loss In...
While reporting financial results for the first quarter on Thursday, Charles River Laboratories International, Inc. (CRL) reaffirmed its adjusted earnings and organic revenue growth guidance...
-
Charles River beats quarterly estimates on steady demand for drug development services
Contract drug developer Charles River Laboratories on Thursday beat Wall Street expectations for first-quarter results, helped by improved demand for its drug discovery and development...
Track Charles River and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Charles River competitors & trending companies
Browse news for competitors to Charles River and other trending companies.
Revvity
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove